Duke-NUS discoveries shaping the future of medicine

From unlocking new treatments to pioneering global health initiatives, Duke-NUS scientists are driving discoveries that change lives. Here’s a look at five most exciting developments in this quarter:


Asia’s new hub for mental health innovation launched

 

MHIN Asia Hub launch

In collaboration with the Mental Health Innovation Network (MHIN), the SingHealth Duke-NUS Global Health Institute launched the MHIN Asia Hub on 17 February at the inaugural Global Mental Health in Asia Symposium.

The Hub, which is based in Singapore, aims to share innovative resources and ideas to promote mental health support across Asia.

“Hosting the MHIN Asia Hub underscores our commitment to being at the forefront of global health discussions and innovations. It’s about transforming insights into actions, shaping policies that are both impactful and implementable across Asia’s diverse social, economic, and cultural needs.”

Prof London Lucien Ooi, Director of the SingHealth Duke-NUS Global Health Institute



Unlocking a new therapeutic target for treating heart disease 

We now see them (supercomplexes) as critical back-up systems that kick in to sustain energy when the primary sources falter. Our next challenge is to activate these back-up systems proactively, without waiting for a stress trigger.” 

Assoc Prof Lena Ho

SC-XL: A specialized respiratory supercomplex that improves respiratory efficiency and protects against mitochondrial stress. // Credit: Lena Ho & James Letts

Scientists at Duke-NUS have discovered a protein supercomplex, termed SC-XL, that helps generate energy even when blood flow to the heart is reduced during ischaemic stress.

Their findings, published in Cell Metabolism, offer new therapeutic avenues for the treatment of ischaemic heart disease—a leading cause of death worldwide.




New findings offer hope for treating pulmonary fibrosis

 “Next, we will further validate the roles of YAP and TAZ in the disease and confirm the effectiveness of therapies that inhibit these proteins, offering patients better outcomes.”

Assoc Prof Manvendra Kumar Singh

An inflamed lung (left) and a healthy lung (right), artistically depicted by an AI. // Generated by Manvendra Kumar Singh using Adobe Express

A team of Duke-NUS scientists has found that blocking specific proteins in immune cells could significantly reduce or reverse lung scarring. Found in macrophages, the proteins—YAP and TAZ—can curb scar formation and enhance regeneration.

The study, published in the European Respiratory Journal, paves the way for novel treatments that could potentially reverse damage from pulmonary fibrosis.




Probiotics for better mental health? The gut-brain connection grows stronger

 

A crucial connection between gut microbes and anxiety-related behaviour has been discovered by a team of scientists from Duke-NUS and the National Neuroscience Institute. Their findings suggest that microbial metabolites—specifically indoles—play a direct role in regulating brain activity linked to anxiety. 

The study, published in EMBO Molecular Medicine, opens up exciting possibilities for new probiotic-based therapies to improve mental health.

“Our findings reveal the specific and intricate neural process that links microbes to mental health. Those [mice] without any live microbes showed higher levels of anxious behaviour than those with live bacteria. Essentially, the lack of these microbes disrupted the way their brains functioned, particularly in areas that control fear and anxiety, leading to anxious behaviour.” 

Assoc Prof Shawn Je




Fighting infections from inside the womb
A 3D reconstruction of a Zika virus-infected mouse embryo on embryonic day 10.5, imaged by light sheet microscope. // Credit: Chinmay Mantri

While it was once thought that the mother’s immune system was the sole source of protection from infection for a foetus, a recent finding by a team of Duke-NUS scientists suggests otherwise, with foetuses capable of mounting their own immune response. Significantly, the scientists found that the outcome of an infection varies depending on the immune cell—with monocytes causing inflammatory damage to a developing foetal brain and microglia taking on a protective role.

This breakthrough discovery, published in Cell, offers new approaches to protecting foetuses’ brain health by reducing harmful inflammation.

“Our work has shown that the immune responses of foetuses can be either protective or harmful. Knowing how various immune cells contribute to foetal immune protection will be important in our continued search for ways to improve pregnancy outcomes.”

Assoc Prof Ashley St John

Get the latest news and features delivered to your inbox.
SUBSCRIBE TO MEDICUS